Chemistry Journal Defamed Cardiac Testing Co., Suit Says

Law360, New York (June 6, 2013, 9:19 PM EDT) -- Medical products maker Critical Care Diagnostics Inc. has filed a defamation suit in California federal court against the publisher of Clinical Chemistry alleging an article in the scientific journal included false statements disparaging its blood test for assessing the mortality risk of patients with chronic heart failure.

The article about “cardiac biomarker” tests used to measure levels of the ST2 protein in the blood falsely stated or implied that Critical Care's Presage Assay product is less effective than a rival product being developed by Alere Inc.,...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Critical Care Diagnostics, Inc. v. American Association For Clinical Chemistry, Inc. et al


Case Number

3:13-cv-01308

Court

California Southern

Nature of Suit

Personal Property: Other

Judge

M. James Lorenz

Date Filed

June 5, 2013

Law Firms

Companies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.